The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
PAINS: Relevance to Tool Compound Discovery and Fragment-Based Screening
Abstract
Pan assay interference compounds (PAINS) are readily discovered in any bioassay and can appear to give selective and optimisable hits. The most common PAINS can be readily recognised by their structure. However, there are compounds that closely resemble PAINS that are not specifically recognised by the PAINS filters. In addition, highly reactive compounds are not encoded for in the PAINS filters because they were excluded from the high-throughput screening (HTS) library used to develop the filters and so were never present to provide indicting data. A compounding complication in the area is that very occasionally a PAINS compound may serve as a viable starting point for progression. Despite such an occasional example, the literature is littered with an overwhelming number of examples of compounds that fail to progress and were probably not optimisable in the first place, nor useful tool compounds. Thus it is with great caution and diligence that compounds possessing a known PAINS core should be progressed through to medicinal chemistry optimisation, if at all, as the chances are very high that the hits will be found to be non-progressable, often after a significant waste of resources.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some commonly used molecular probes are also thiol-reactive (Baell, 2010; Baell et al., 2013; Dahlin et al., 2015c).”
From ALARM NMR for HTS Triage and Chemical Probe Validation (2018) · cites this paper as Baell et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Min, S.-W., Cho, S.-H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W. W., Huang, E. J., Shen, Y., Masliah, E., Mukherjee, C., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.044 · Cited by 949
Bowers, E. M., Yan, G., Mukherjee, C., Orry, A., Wang, L., Holbert, M. A., Crump, N. T., Hazzalin, C. A., Liszczak, G., Yuan, H., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.03.006 · Cited by 666
Mali, P., Chou, B.-K., Yen, J., Ye, Z., Zou, J., Dowey, S., Brodsky, R. A., Ohm, J. E., Yu, W., Baylin, S. B., et al. (2010) · Stem Cells · doi:10.1002/stem.402 · Cited by 417
Identification and Characterization of the First Small Molecule Inhibitor of MDMX
Reed, D., Shen, Y., Shelat, A. A., Arnold, L. A., Ferreira, A. M., Zhu, F., Mills, N., Smithson, D. C., Regni, C. A., Bashford, D., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056747 · Cited by 198
On the Mechanism of Action of SJ-172550 in Inhibiting the Interaction of MDM4 and p53
Bista, M., Smithson, D., Pecak, A., Salinas, G., Pustelny, K., Min, J., Pirog, A., Finch, K., Zdzalik, M., Waddell, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037518 · Cited by 58
Research works printed but not linked: 67
- Baell, 2010, J. Med. Chem., 53, 2719, 10.1021/JM901137J · DOI · Paper page
- Baell, 2010, Future Med. Chem., 2, 1529, 10.4155/FMC.10.237 · DOI · Paper page
- Powers, 2006, J. Med. Chem., 49, 1034, 10.1021/JM050859X · DOI
- Carter, 2001, Proc. Natl. Acad. Sci. USA, 98, 11879, 10.1073/PNAS.211178398 · DOI
- Voss, 2003, Bioorg. Med. Chem. Lett., 13, 533, 10.1016/S0960-894X(02)00941-1 · DOI
- Carlson, 2006, Chem. Biol., 13, 825, 10.1016/J.CHEMBIOL.2006.06.007 · DOI
- Lee, 2006, J. Mol. Biol., 357, 1051, 10.1016/J.JMB.2006.01.032 · DOI
- Metz, 2007, J. Comput. Aided Mol. Des., 21, 139, 10.1007/S10822-007-9109-Z · DOI
- Huth, 2007, Chem. Res. Toxicol., 20, 1752, 10.1021/TX700319T · DOI · Paper page
- Tanaka, 1988, Chem. Pharm. Bull., 36, 60, 10.1248/CPB.36.60 · doi:10.1248/cpb.36.60
- Meissner, 1994, Tetrahedron Lett., 35, 2757, 10.1016/S0040-4039(00)77025-0 · doi:10.1016/s0040-4039(00)77025-0
- Tanaka, 1988, Tetrahedron, 44, 3241, 10.1016/S0040-4020(01)85957-3 · doi:10.1016/s0040-4020(01)85957-3
- Forino, 2005, Proc. Natl. Acad. Sci. USA, 102, 9499, 10.1073/PNAS.0502733102 · DOI
- Tjernberg, 2004, Bioorg. Med. Chem. Lett., 14, 891, 10.1016/J.BMCL.2003.12.014 · DOI
- McCallum, 2013, J. Biomol. Screen., 18, 705, 10.1177/1087057113476090 · DOI
- Huth, 2005, J. Am. Chem. Soc., 127, 217, 10.1021/JA0455547 · DOI · Paper page
- Sleno, 2007, Rapid Commun. Mass Spectrom., 21, 2301, 10.1002/RCM.3092 · DOI
- Dietrich, 2008, Science, 321, 1203, 10.1126/SCIENCE.1160619 · DOI · Paper page
- Li, 2005, J. Am. Chem. Soc., 127, 6140, 10.1021/JA050974X · DOI
- Liu, 2003, Arch. Pharm. Res., 26, 1047, 10.1007/BF02994757 · doi:10.1007/bf02994757
- Ifa, 2000, J. Mol. Struct. THEOCHEM, 505, 11, 10.1016/S0166-1280(99)00307-3 · doi:10.1016/s0166-1280(99)00307-3
- Ledesma, 1998, Polyhedron, 17, 1517, 10.1016/S0277-5387(97)00413-0 · doi:10.1016/s0277-5387(97)00413-0
- Ainscough, 1999, J. Inorg. Biochem., 77, 125, 10.1016/S0162-0134(99)00131-2 · DOI
- McGovern, 2002, J. Med. Chem., 45, 1712, 10.1021/JM010533Y · DOI · Paper page
- Herzig, 2006, J. Org. Chem., 71, 4130, 10.1021/JO052621M · doi:10.1021/jo052621m
- Weinert, 2006, J. Am. Chem. Soc., 128, 11940, 10.1021/JA062948K · DOI · Paper page
- McLean, 2009, Bioorg. Med. Chem. Lett., 19, 6717, 10.1016/J.BMCL.2009.09.106 · DOI
- Caulfield, 2001, Aust. J. Chem., 54, 383, 10.1071/CH01066 · doi:10.1071/ch01066
- Occhipinti, 2007, Organometallics, 26, 5803, 10.1021/OM070219N · DOI
- Xie, 2003, Eur. J. Inorg. Chem., 2003, 4010, 10.1002/EJIC.200300384 · doi:10.1002/ejic.200300384
- Ghailane, 2000, J. Mol. Struct. THEOCHEM, 531, 223, 10.1016/S0166-1280(00)00445-0 · doi:10.1016/s0166-1280(00)00445-0
- Baell, 2013, J. Chem. Inf. Model., 53, 39, 10.1021/CI300461A · DOI
- Uchiyama, 2002, J. Chromatogr. A, 982, 111, 10.1016/S0021-9673(02)01274-8 · doi:10.1016/s0021-9673(02)01274-8
- Uchiyama, 2001, Biomed. Chromatogr., 15, 295, 10.1002/BMC.75 · doi:10.1002/bmc.75
- Park, 2009, Chem. Biol., 16, 763, 10.1016/J.CHEMBIOL.2009.06.005 · DOI
- Tanakit, 2012, Dalton Trans., 41, 6507, 10.1039/C2DT12373H · DOI
- Camps, 2005, Nat. Med., 11, 936, 10.1038/nm1284 · DOI · Paper page
- Barber, 2005, Nat. Med., 11, 933, 10.1038/nm1291 · DOI · Paper page
- Pomel, 2006, J. Med. Chem., 49, 3857, 10.1021/JM0601598 · DOI · Paper page
- Knight, 2010, ACS Med. Chem. Lett., 1, 39, 10.1021/ML900028R · DOI · Paper page
- Dakin, 2012, Bioorg. Med. Chem. Lett., 22, 4599, 10.1016/J.BMCL.2012.05.098 · DOI
- Seto, 2013, Cancer Chemother. Pharmacol., 72, 619, 10.1007/S00280-013-2234-6 · DOI
- Mendgen, 2012, J. Med. Chem., 55, 743, 10.1021/JM201243P · DOI · Paper page
- Tomasic, 2009, Curr. Med. Chem., 16, 1596, 10.2174/092986709788186200 · DOI · Paper page
- Tomasic, 2012, Expert Opin. Drug Dis., 7, 549, 10.1517/17460441.2012.688743 · DOI · Paper page
- Moreau, 2008, Bioorg. Med. Chem. Lett., 18, 4022, 10.1016/J.BMCL.2008.05.117 · DOI
- Cosner, 2009, J. Med. Chem., 52, 6494, 10.1021/JM900707N · DOI
- Pipalia, 2006, J. Lipid Res., 47, 284, 10.1194/JLR.M500388-JLR200 · DOI
- Hu, 2004, Chem. Biol., 11, 703, 10.1016/J.CHEMBIOL.2004.02.024 · DOI
- Waltenberger, 2011, J. Med. Chem., 54, 3163, 10.1021/JM101309G · DOI
- Park, 2012, Bioorg. Med. Chem. Lett., 22, 1271, 10.1016/J.BMCL.2011.10.083 · DOI
- Cencic, 2011, Proc. Natl. Acad. Sci. USA, 108, 1046, 10.1073/PNAS.1011477108 · DOI · Paper page
- Xu, 2011, Science, 332, 963, 10.1126/SCIENCE.1202845 · DOI · Paper page
- Marek, 2011, J. Neurosci., 31, 7486, 10.1523/JNEUROSCI.0133-11.2011 · DOI
- Crump, 2011, Proc. Natl. Acad. Sci. USA, 108, 7814, 10.1073/PNAS.1100099108 · DOI
- Reynoird, 2010, EMBO J., 29, 2943, 10.1038/EMBOJ.2010.176 · DOI · Paper page
- Hao, 2013, Cell Reports, 4, 898, 10.1016/J.CELREP.2013.07.047 · DOI
- D’Arcy, 2011, Nat. Med., 17, 1636, 10.1038/NM.2536 · DOI · Paper page
- Lessene, 2013, Nat. Chem. Biol., 9, 390, 10.1038/NCHEMBIO.1246 · DOI · Paper page
- Sleebs, 2013, J. Med. Chem., 56, 5514, 10.1021/JM400556W · DOI
- Sleebs, 2011, Bioorg. Med. Chem. Lett., 21, 5992, 10.1016/J.BMCL.2011.07.050 · doi:10.1016/j.bmcl.2011.07.050
- Sleebs, 2011, Med. Chem. Commun., 2, 977, 10.1039/C1MD00137J · doi:10.1039/c1md00137j
- Sleebs, 2011, Med. Chem. Commun., 2, 982, 10.1039/C1MD00138H · doi:10.1039/c1md00138h
- Li, 2013, Clin. Exp. Metastasis, 30, 483, 10.1007/S10585-012-9553-6 · DOI
- Baell, 2011, Drug Discov. Today, 16, 840, 10.1016/J.DRUDIS.2011.06.011 · doi:10.1016/j.drudis.2011.06.011
- Zeller, 2013, Bioorg. Med. Chem. Lett., 23, 5814, 10.1016/J.BMCL.2013.08.111 · DOI
- Davis, 2013, Bioorg. Med. Chem. Lett., 23, 2844, 10.1016/J.BMCL.2013.03.028 · DOI
Cited by
Chemistry: Chemical con artists foil drug discovery
Baell, J., & Walters, M. A. (2014) · Nature · doi:10.1038/513481a · Cited by 1,043
Self-citationSeven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017—Utility and Limitations
Baell, J. B., & Nissink, J. W. M. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00903 · Cited by 648
Self-citationBaell, J. B. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00947 · Cited by 539
Self-citationDahlin, J. L., Nissink, J. W. M., Strasser, J. M., Francis, S., Higgins, L., Zhou, H., Zhang, Z., & Walters, M. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5019093 · Cited by 351
ALARM NMR for HTS Triage and Chemical Probe Validation
Dahlin, J. L., Cuellar, M., Singh, G., Nelson, K. M., Strasser, J. M., Rappe, T., Xia, Y., Veglia, G., & Walters, M. A. (2018) · Current Protocols in Chemical Biology · doi:10.1002/cpch.35 · Cited by 25
Metadata
- Authors
- Baell, J. B., Ferrins, L., Falk, H., & Nikolakopoulos, G.
- Affiliations
- AMedicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Vic. 3052, Australia.
- BThe Walter and Eliza Hall Institute of Medical Research, Parkville, Vic. 3052, Australia.
- Venue
- Australian Journal of Chemistry
- Publisher
- CSIRO Publishing
- Published
- 2013-12-02
- Volume
- 66
- Issue
- 12
- Pages
- 1483-1494
- ISSN
- 0004-9425
- 1445-0038
- Cited by
- 84
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.